Blake I Narramore

Array ( [id] => 3731165 [patent_doc_number] => 05635499 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Medicinal products and pure preparations of melarsomine dihydrochloride, process for obtaining them and intermediate products obtained' [patent_app_type] => 1 [patent_app_number] => 8/459797 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3431 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635499.pdf [firstpage_image] =>[orig_patent_app_number] => 459797 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771670 [patent_doc_number] => 05756494 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Protein kinase inhibitors for treatment of neurological disorders' [patent_app_type] => 1 [patent_app_number] => 8/456642 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 29 [patent_no_of_words] => 27955 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756494.pdf [firstpage_image] =>[orig_patent_app_number] => 456642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3831934 [patent_doc_number] => 05760282 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Process for the manufacture of selected halogenated hydrocarbons containing fluorine and hydrogen and compositions provided therein' [patent_app_type] => 1 [patent_app_number] => 8/459011 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20685 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760282.pdf [firstpage_image] =>[orig_patent_app_number] => 459011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3702496 [patent_doc_number] => 05674862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-07 [patent_title] => 'Methods of treating diabetic mellitus and its complications' [patent_app_type] => 1 [patent_app_number] => 8/457060 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37963 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/674/05674862.pdf [firstpage_image] =>[orig_patent_app_number] => 457060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586997 [patent_doc_number] => 05552396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Protein kinase c inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/457000 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37892 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552396.pdf [firstpage_image] =>[orig_patent_app_number] => 457000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3627733 [patent_doc_number] => 05621098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Process for preparing bis-indolyl macrocycles' [patent_app_type] => 1 [patent_app_number] => 8/457657 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37968 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 275 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/621/05621098.pdf [firstpage_image] =>[orig_patent_app_number] => 457657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3733483 [patent_doc_number] => 05693790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Crystalline form of a cephalosporin antibiotic' [patent_app_type] => 1 [patent_app_number] => 8/455136 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3035 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693790.pdf [firstpage_image] =>[orig_patent_app_number] => 455136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688324 [patent_doc_number] => 05696124 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Xanthine derivatives with adenosine-antagonistic activity' [patent_app_type] => 1 [patent_app_number] => 8/454452 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8785 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696124.pdf [firstpage_image] =>[orig_patent_app_number] => 454452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795619 [patent_doc_number] => 05780626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Oxazine compounds' [patent_app_type] => 1 [patent_app_number] => 8/451279 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4858 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780626.pdf [firstpage_image] =>[orig_patent_app_number] => 451279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3653091 [patent_doc_number] => 05622688 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'Macrocyclic chelants, their chelates and uses thereof in the diagnostic field' [patent_app_type] => 1 [patent_app_number] => 8/448742 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6968 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 423 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622688.pdf [firstpage_image] =>[orig_patent_app_number] => 448742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3510297 [patent_doc_number] => 05587378 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-24 [patent_title] => 'Therapeutic agent for Parkinson\'s disease' [patent_app_type] => 1 [patent_app_number] => 8/447885 [patent_app_country] => US [patent_app_date] => 1995-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53040 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 263 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/587/05587378.pdf [firstpage_image] =>[orig_patent_app_number] => 447885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624676 [patent_doc_number] => 05594133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropinonyloxy)-ethyl-3-cephem-4-carboxylate' [patent_app_type] => 1 [patent_app_number] => 8/447045 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6728 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/594/05594133.pdf [firstpage_image] =>[orig_patent_app_number] => 447045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622610 [patent_doc_number] => 05614623 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Diastereomers of 1-(isopropoxycarbonyloxy)ethyl 3-cephem-4-carboxylate and processes for their preparation' [patent_app_type] => 1 [patent_app_number] => 8/447249 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4591 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614623.pdf [firstpage_image] =>[orig_patent_app_number] => 447249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723603 [patent_doc_number] => 05672583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Carboxy-peptidyl derivatives as antidegenerative active agents' [patent_app_type] => 1 [patent_app_number] => 8/436347 [patent_app_country] => US [patent_app_date] => 1995-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33508 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 813 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672583.pdf [firstpage_image] =>[orig_patent_app_number] => 436347 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3646692 [patent_doc_number] => 05637578 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-10 [patent_title] => 'Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide' [patent_app_type] => 1 [patent_app_number] => 8/442454 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 48876 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 933 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/637/05637578.pdf [firstpage_image] =>[orig_patent_app_number] => 442454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3650466 [patent_doc_number] => 05605929 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Methods and compositions for inhibiting 5.alpha.-reductase activity' [patent_app_type] => 1 [patent_app_number] => 8/442055 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 42 [patent_no_of_words] => 28116 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/605/05605929.pdf [firstpage_image] =>[orig_patent_app_number] => 442055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3636096 [patent_doc_number] => 05610293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-11 [patent_title] => 'Methods of preparing manganese complexes of nitrogen-containing macrocyclic ligands' [patent_app_type] => 1 [patent_app_number] => 8/442455 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49630 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/610/05610293.pdf [firstpage_image] =>[orig_patent_app_number] => 442455 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4177007 [patent_doc_number] => 06084093 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide' [patent_app_type] => 1 [patent_app_number] => 8/442147 [patent_app_country] => US [patent_app_date] => 1995-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 49625 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 703 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/084/06084093.pdf [firstpage_image] =>[orig_patent_app_number] => 442147 [rel_patent_id] =>[rel_patent_doc_number] =>)